Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation - PubMed (original) (raw)
. 2004 Mar 4;23(9):1645-55.
doi: 10.1038/sj.onc.1207298.
Affiliations
- PMID: 14661060
- DOI: 10.1038/sj.onc.1207298
Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation
Minsoo Kim et al. Oncogene. 2004.
Erratum in
- Oncogene. 2004 Oct 14;23(47):7903-4
Abstract
The Cbl family proteins Cbl, Cbl-b, and Cbl-c/Cbl-3 are thought to regulate signaling through protein-tyrosine kinases, positively as scaffold proteins and negatively as ubiquitin ligases. However, the precise signaling pathways and target proteins for each Cbl family member are not well understood. Here we show that Src is a preferential target of Cbl-c for degradation. Although exogenous expression of all Cbl family proteins suppressed the anchorage-independent growth of v-Src-transformed NIH3T3 cells, only Cbl-c caused reversion of the refractile morphology. The level of v-Src protein was reduced by Cbl-c, possibly through a lysosome-dependent pathway. The TKB domain and RING finger of Cbl-c were important for its antioncogenic activity. Wild-type Cbl-c promoted ubiquitination of Src in 293T cells, whereas a RING finger mutant did not. Cbl-c bound specifically to Src phosphorylated at Tyr419. Furthermore, Cbl-c together with UbcH5 induced ubiquitination of Src in vitro. Importantly, the Tyr419 nonphosphorylated form of Src was not ubiquitinated by Cbl-c. Therefore, activated Src may be a direct target of Cbl-c in vivo. Our results suggest that Cbl and Cbl-b suppress v-Src-induced transformation through mechanisms distinct from that of Cbl-c.
Similar articles
- Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
Bisson SA, Ujack EE, Robbins SM. Bisson SA, et al. Oncogene. 2002 May 23;21(23):3677-87. doi: 10.1038/sj.onc.1205510. Oncogene. 2002. PMID: 12032836 - c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts.
Odai H, Sasaki K, Hanazono Y, Ueno H, Tanaka T, Miyagawa K, Mitani K, Yazaki Y, Hirai H. Odai H, et al. Jpn J Cancer Res. 1995 Dec;86(12):1119-26. doi: 10.1111/j.1349-7006.1995.tb03303.x. Jpn J Cancer Res. 1995. PMID: 8635998 Free PMC article. - Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation.
Howlett CJ, Robbins SM. Howlett CJ, et al. Oncogene. 2002 Mar 7;21(11):1707-16. doi: 10.1038/sj.onc.1205228. Oncogene. 2002. PMID: 11896602 - The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.
Rao N, Dodge I, Band H. Rao N, et al. J Leukoc Biol. 2002 May;71(5):753-63. J Leukoc Biol. 2002. PMID: 11994499 Review. - Beyond the RING: CBL proteins as multivalent adapters.
Tsygankov AY, Teckchandani AM, Feshchenko EA, Swaminathan G. Tsygankov AY, et al. Oncogene. 2001 Oct 1;20(44):6382-402. doi: 10.1038/sj.onc.1204781. Oncogene. 2001. PMID: 11607840 Review.
Cited by
- Inhibition of TFII-I-dependent cell cycle regulation by p53.
Desgranges ZP, Ahn J, Lazebnik MB, Ashworth T, Lee C, Pestell RC, Rosenberg N, Prives C, Roy AL. Desgranges ZP, et al. Mol Cell Biol. 2005 Dec;25(24):10940-52. doi: 10.1128/MCB.25.24.10940-10952.2005. Mol Cell Biol. 2005. PMID: 16314517 Free PMC article. - Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis.
Gu R, Kim TD, Jiang H, Shin S, Oh S, Janknecht R. Gu R, et al. Front Oncol. 2023 Nov 17;13:1295613. doi: 10.3389/fonc.2023.1295613. eCollection 2023. Front Oncol. 2023. PMID: 38045004 Free PMC article. - The Ubiquitin Ligase CBLC Maintains the Network Organization of the Golgi Apparatus.
Lee WY, Goh G, Chia J, Boey A, Gunko NV, Bard F. Lee WY, et al. PLoS One. 2015 Sep 22;10(9):e0138789. doi: 10.1371/journal.pone.0138789. eCollection 2015. PLoS One. 2015. PMID: 26393512 Free PMC article. - Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh AR, Ernst M. Poh AR, et al. Oncogene. 2023 Jun;42(22):1786-1801. doi: 10.1038/s41388-023-02701-x. Epub 2023 Apr 29. Oncogene. 2023. PMID: 37120696 Free PMC article. Review. - Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A.
Kales SC, Nau MM, Merchant AS, Lipkowitz S. Kales SC, et al. PLoS One. 2014 Jan 23;9(1):e87116. doi: 10.1371/journal.pone.0087116. eCollection 2014. PLoS One. 2014. PMID: 24466333 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous